{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:59Z","timestamp":1793383019956,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001634","name":"University of Galway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020396","name":"Alzheimers New Zealand","doi-asserted-by":"publisher","award":["3718869"],"award-info":[{"award-number":["3718869"]}],"id":[{"id":"10.13039\/501100020396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["3723033"],"award-info":[{"award-number":["3723033"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020395","name":"Alzheimers New Zealand Charitable Trust Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003189","name":"Freemasons New Zealand","doi-asserted-by":"publisher","award":["3719321"],"award-info":[{"award-number":["3719321"]}],"id":[{"id":"10.13039\/501100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014191","name":"The University of Auckland Brain Research New Zealand","doi-asserted-by":"publisher","award":["3710638"],"award-info":[{"award-number":["3710638"]}],"id":[{"id":"10.13039\/501100014191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","award":["110089.01"],"award-info":[{"award-number":["110089.01"]}],"id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021732","name":"Aotearoa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuropharm.2026.110892","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:43:58Z","timestamp":1771832638000},"page":"110892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The \u03b2-amyloid-induced increased tonic conductance, impaired long-term potentiation and cognitive deficits characteristic of Alzheimer's disease are reversed by an \u03b15 inverse agonist of the GABA type A receptor"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8757-7942","authenticated-orcid":false,"given":"Aoife","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Calvo-Flores Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron N.","family":"Keighron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Boix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Peppercorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-7734","authenticated-orcid":false,"given":"Warren P.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Waldvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-9498","authenticated-orcid":false,"given":"Richard LM.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-6732","authenticated-orcid":false,"given":"Leo","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-4956","authenticated-orcid":false,"given":"Andrea","family":"Kwakowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110892_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot091298","article-title":"Long-term potentiation by theta-burst stimulation using extracellular field potential recordings in acute hippocampal slices","volume":"2016","author":"Abrahamsson","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.neuropharm.2026.110892_bib2","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.18632\/aging.101672","article-title":"Gender, GABAergic dysfunction and AD","volume":"10","author":"Alia","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2026.110892_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110892_bib4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/cns.13914","article-title":"Effects of \u03b15 GABA(A) receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease","volume":"28","author":"Aran\u0111elovi\u0107","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.110892_bib5","first-page":"25","article-title":"GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2\/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer","volume":"14","author":"Atack","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.110892_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.110892_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1476-5381.2009.00216.x","article-title":"The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates","volume":"157","author":"Atack","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110892_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn2044","article-title":"Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks","volume":"8","author":"Bartos","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2024.12.001","article-title":"Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer's disease pathology","volume":"147","author":"Bernardo","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2026.110892_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hipo.22141","article-title":"Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity","volume":"23","author":"Bezaire","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2026.110892_bib12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/alz.12088","article-title":"GABAergic dysfunction in excitatory and inhibitory (E\/I) imbalance drives the pathogenesis of Alzheimer's disease","volume":"16","author":"Bi","year":"2020","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110892_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor \u03b15 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib14","article-title":"Chronic treatment with a promnesiant GABA-A \u03b15-Selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down Syndrome mouse model","volume":"2011","author":"Braudeau","year":"2011","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jnc.14345","article-title":"The GABAergic system as a therapeutic target for Alzheimer's disease","volume":"146","author":"Calvo-Flores Guzman","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110892_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030693","article-title":"Amyloid-Beta(1-42) -Induced increase in GABAergic tonic conductance in mouse hippocampal CA1 pyramidal cells","volume":"25","author":"Calvo-Flores Guzman","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.110892_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.552073","article-title":"The interplay between beta-amyloid 1-42 (Abeta(1-42))-Induced hippocampal inflammatory response, p-tau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits","volume":"13","author":"Calvo-Flores Guzman","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02140-w","article-title":"The GABAergic system in Alzheimer's disease: a systematic review with meta-analysis","author":"Carello-Collar","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110892_bib20","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1021\/jm040863t","article-title":"An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA \u03b15 receptors with cognition enhancing properties","volume":"47","author":"Chambers","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110892_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuro.2022.12.007","article-title":"Naringin enhances long-term potentiation and recovers learning and memory deficits of amyloid-beta induced Alzheimer's disease-like behavioral rat model","volume":"95","author":"Choi","year":"2023","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib22","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00213-006-0361-z","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the morris water maze","volume":"188","author":"Collinson","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110892_bib24","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110892_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2020.09.037","article-title":"Relocation of an extrasynaptic GABA(A) receptor to inhibitory synapses freezes excitatory synaptic strength and preserves memory","volume":"109","author":"Davenport","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110892_bib26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110892_bib27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/bph.14903","article-title":"Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an \u03b15-selective GABA(A) inverse agonist","volume":"177","author":"Duchon","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.neuropharm.2010.07.024","article-title":"Occupancy of human brain GABA(A) receptors by the novel \u03b15 subtype-selective benzodiazepine site inverse agonist \u03b15IA as measured using [11C]flumazenil PET imaging","volume":"59","author":"Eng","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer's disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2026.110892_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2016.04.009","article-title":"Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during hippocampal sharp-wave ripples","volume":"90","author":"Gillespie","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110892_bib31","article-title":"Restoring memory by optogenetic synchronization of hippocampal oscillations in an Alzheimer's disease mouse model","author":"Giovannetti","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2026.110892_bib32","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1152\/jn.01122.2005","article-title":"Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor \u03b15 subunit\u2013deficient mice","volume":"95","author":"Glykys","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA(A)-\u03b15 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2026.110892_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081813","article-title":"Towards a better understanding of GABAergic remodeling in Alzheimer's disease","volume":"18","author":"Govindpani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib35","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.1523\/JNEUROSCI.19-22-10082.1999","article-title":"Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus","volume":"19","author":"Guly\u00e1s","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib36","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1046\/j.1460-9568.2000.00164.x","article-title":"beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis","volume":"12","author":"Harkany","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib37","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41598-021-87307-7","article-title":"Basmisanil, a highly selective GABA(A)-\u03b15 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man","volume":"11","author":"Hipp","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110892_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(00)00163-9","article-title":"Density and pharmacology of \u03b15 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer's disease patients","volume":"98","author":"Howell","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110892_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110892_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","article-title":"GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease","volume":"116","author":"Jim\u00e9nez-Balado","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.3639","article-title":"GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease","volume":"20","author":"Jo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.110892_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2018.11.003","article-title":"Enhanced GABAergic tonic inhibition reduces intrinsic excitability of hippocampal CA1 pyramidal cells in experimental autoimmune encephalomyelitis","volume":"395","author":"Kammel","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110892_bib43","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1110\/ps.8.8.1668","article-title":"Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused","volume":"8","author":"Kapust","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.117.247627","article-title":"ONO-8590580, a novel GABA(A)\u03b15 negative allosteric modulator enhances long-term potentiation and improves cognitive deficits in preclinical models","volume":"366","author":"Kawaharada","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110892_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0006-8993(91)91140-V","article-title":"Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death","volume":"548","author":"Koh","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110892_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2012.06.023","article-title":"Selective GABA(A) \u03b15 positive allosteric modulators improve cognitive function in aged rats with memory impairment","volume":"64","author":"Koh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep21101","article-title":"Treatment of beta amyloid 1\u201342 (A\u03b21\u201342)-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo","volume":"6","author":"Kwakowsky","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110892_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/srep21101","article-title":"Treatment of beta amyloid 1-42 (A\u03b2(1-42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo","volume":"6","author":"Kwakowsky","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110892_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jnc.14325","article-title":"GABA(A) receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus","volume":"145","author":"Kwakowsky","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110892_bib50","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4103\/1673-5374.235240","article-title":"Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway","volume":"13","author":"Kwakowsky","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110892_bib51","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4103\/1673-5374.300987","article-title":"Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer's disease","volume":"16","author":"Kwakowsky","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110892_bib52","article-title":"The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type","volume":"8","author":"Lee","year":"2014","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2026.110892_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer's disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-200188","article-title":"Muscone ameliorates synaptic dysfunction and cognitive deficits in APP\/PS1 mice","volume":"76","author":"Liu","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2026.110892_bib55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0306-4522(99)00548-5","article-title":"Glutamate dependence of GABA levels in neurons of hypoxic and hypoglycemic rat hippocampal slices","volume":"96","author":"Madl","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110892_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tins.2007.05.003","article-title":"Role of GABAergic inhibition in hippocampal network oscillations","volume":"30","author":"Mann","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1113\/jphysiol.2004.078758","article-title":"Hippocampal gamma-frequency oscillations: from interneurones to pyramidal cells, and back","volume":"562","author":"Mann","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib58","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bja.2020.11.032","article-title":"Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of \u03b15 subunit-containing \u03b3-aminobutyric acid type A receptors: implications for treating cognitive deficits","volume":"126","author":"Manzo","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2026.110892_bib59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/ALN.0b013e3181bbc961","article-title":"Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade","volume":"111","author":"Martin","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep38242","article-title":"Electrophysiological properties of CA1 pyramidal neurons along the longitudinal axis of the mouse hippocampus","volume":"6","author":"Milior","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110892_bib61","doi-asserted-by":"crossref","first-page":"P210","DOI":"10.1016\/j.jalz.2018.06.2324","article-title":"PL-01-02: aberrant network activity in ALZHEIMER'S disease: preclinical investigation to clinical trials","volume":"14","author":"Mucke","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110892_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109587","article-title":"Long-term \u03b15 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition","volume":"237","author":"Nuwer","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110892_bib65","article-title":"\u03b2-amyloid\u2019s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review","volume":"209","author":"O'Connell","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.110892_bib66","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib67","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110892_bib68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(97)01205-8","article-title":"A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity","volume":"21","author":"Paulsen","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.568194","article-title":"Selective modulation of \u03b15 GABAA receptors exacerbates aberrant inhibition at key hippocampal neuronal circuits in APP mouse model of alzheimer's disease","volume":"14","author":"Petrache","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07895","article-title":"Prodromal dysfunction of \u03b15GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer's disease","volume":"7","author":"Ratner","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2026.110892_bib71","first-page":"613","article-title":"Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease","volume":"117","author":"Rissman","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110892_bib72","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1471-4159.2007.04832.x","article-title":"GABA(A) receptors in aging and Alzheimer's disease","volume":"103","author":"Rissman","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110892_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15306-8","article-title":"Activation of G-protein-gated inwardly rectifying potassium (Kir3\/GirK) channels rescues hippocampal functions in a mouse model of early amyloid-\u03b2 pathology","volume":"7","author":"S\u00e1nchez-Rodr\u00edguez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110892_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051168","article-title":"Role of GirK channels in long-term potentiation of synaptic inhibition in an in vivo mouse model of early Amyloid-\u03b2 pathology","volume":"20","author":"S\u00e1nchez-Rodr\u00edguez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib75","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ncomms1377","article-title":"Tonic excitation or inhibition is set by GABA(A) conductance in hippocampal interneurons","volume":"2","author":"Song","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110892_bib76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer's disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib77","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hipo.22403","article-title":"Intrinsic excitability changes induced by acute treatment of hippocampal CA1 pyramidal neurons with exogenous amyloid \u03b2 peptide","volume":"25","author":"Tamagnini","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2026.110892_bib78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.2004.071191","article-title":"Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro","volume":"559","author":"Towers","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/584314","article-title":"Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors","volume":"2014","author":"Varga","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2026.110892_bib80","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110892_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093284","article-title":"An 5 GABAA receptor inverse agonist, 5IA, attenuates amyloid beta-induced neuronal death in mouse hippocampal cultures","volume":"21","author":"Vinnakota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595360","article-title":"Oligomer \u03b2-amyloid induces hyperactivation of ras to impede NMDA receptor-dependent long-term potentiation in hippocampal CA1 of mice","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110892_bib83","series-title":"WHO)","article-title":"World health organisation","year":"2020"},{"key":"10.1016\/j.neuropharm.2026.110892_bib84","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/00001756-199511270-00031","article-title":"beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus","volume":"6","author":"Wu","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.110892_bib85","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/ncomms5159","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110892_bib86","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer' s disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110892_bib87","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00213-018-4832-9","article-title":"Negative allosteric modulation of alpha 5-containing GABA(A) receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice","volume":"235","author":"Xu","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110892_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in alzheimer's disease: implications for treatment","volume":"14","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01427","article-title":"The acute effects of Amyloid-Beta1\u201342 on glutamatergic receptor and transporter expression in the mouse hippocampus","volume":"13","author":"Yeung","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110892_bib90","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1007\/s00213-021-05951-3","article-title":"A multi-dosing regimen to enhance the spatial memory of normal rats with \u03b15-containing GABA(A) receptor negative allosteric modulator L-655,708","volume":"238","author":"Yuan","year":"2021","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:38:14Z","timestamp":1779251894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":89,"alternative-id":["S0028390826000651"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110892","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b2-amyloid-induced increased tonic conductance, impaired long-term potentiation and cognitive deficits characteristic of Alzheimer's disease are reversed by an \u03b15 inverse agonist of the GABA type A receptor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110892"}}